# Submission rejected

## DRAFT REJECTED

**SPAR verdict:** `reject_critical` (3-0 unanimous reject).

## Proposed thesis (rejected)

> Both metabolic and nonmetabolic pathways were significantly influenced, including pyruvate metabolism and DNA repair in muscle and PPAR and SREBP signaling, mitochondrial fatty acid oxidation, and collagen trimerization in adipose.

## Failed citation traces

- **nct_exists** on `C008` (ref=3): NCT01765946 role='published_results' but registry says has_results=False (status=completed). Protocol-as-results contradiction at trace layer.
- **nct_exists** on `C009` (ref=3): NCT01765946 role='published_results' but registry says has_results=False (status=completed). Protocol-as-results contradiction at trace layer.
- **nct_exists** on `C010` (ref=3): NCT01765946 role='published_results' but registry says has_results=False (status=completed). Protocol-as-results contradiction at trace layer.

## Panel reviews

### `evidence_auditor` — `reject` (score 1)

All three claims (C008, C009, C010) rely on a single citation [3] which fails the nct_exists trace. The citation is marked as 'published_results', but the registry for NCT01765946 indicates that results have not been posted (has_results=False). This creates a fundamental contradiction where the evidence source is treated as a results-bearing publication when the trace reveals it is merely a protocol or a study without published results.

**Flagged claims:** C008, C009, C010

### `domain_skeptic` — `reject` (score 3)

The submission suffers from severe mechanism inflation and over-claiming. Claim C010 asserts that specific pathways—including DNA repair in muscle and collagen trimerization in adipose—were 'significantly influenced.' However, the evidence provided is based on differential gene expression (C009). Gene expression changes are proxy markers and do not constitute direct evidence of pathway 'influence' or functional metabolic shifts without accompanying proteomic or biochemical validation. Framing transcriptomic shifts as definitive pathway influence is a classic case of over-claiming.

Furthermore, the reliance on a single source (Ref 3) for all three claims creates a fragile evidentiary base. The jump from 'differentially expressed genes' to specific physiological outcomes like 'mitochondrial fatty acid oxidation' without discussing the magnitude of effect or the biological relevance of these changes is an extrapolation that exceeds the scope of the provided data.

**Flagged claims:** C010

### `final_judge` — `reject` (score 1)

I align with both the Evidence Auditor and the Domain Skeptic, as the submission fails on both evidentiary and conceptual grounds. The Evidence Auditor identified a critical failure in the citation trace: the primary source [3] is linked to a clinical trial registry (NCT01765946) that explicitly lists no results as available. This suggests the claims are based on a protocol or an unpublished study, rendering the factual basis of the entire submission unverifiable and logically void.

Additionally, I concur with the Domain Skeptic regarding the 'mechanism inflation' in C010. Even if the data existed, the leap from differential gene expression (transcriptomics) to definitive claims about functional pathway influence (e.g., collagen trimerization and DNA repair) without proteomic or biochemical validation is an over-extrapolation. The combination of a non-existent results source and an over-reaching interpretation of proxy data makes this submission entirely unacceptable.

**Flagged claims:** C008, C009, C010

## References

[3] Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. (2018). https://pubmed.ncbi.nlm.nih.gov/29383869/
